Valuation: Labcorp Holdings Inc.

Market Cap 21.74B 19.1B 17.6B 16.45B 30.86B 2,052B 31.43B 211B 81.78B 1,011B 81.66B 79.87B 3,515B P/E 2026 *
18.4x
P/E 2027 * 17.2x
Enterprise Value 26.38B 23.17B 21.35B 19.96B 37.44B 2,489B 38.13B 256B 99.21B 1,227B 99.06B 96.89B 4,264B EV / Sales 2026 *
1.79x
EV / Sales 2027 * 1.67x
Free-Float
99.65%
Yield 2026 *
1.1%
Yield 2027 * 1.11%
1 day+0.73%
1 week+4.17%
Current month+2.47%
1 month+3.11%
3 months+0.18%
6 months+4.96%
Current year+6.22%
1 week 253.05
Extreme 253.05
272.05
1 month 253.05
Extreme 253.05
275
Current year 245
Extreme 245
292.02
1 year 241.81
Extreme 241.81
293.72
3 years 191.97
Extreme 191.97
293.72
5 years 191.97
Extreme 191.97
317.17
10 years 98.02
Extreme 98.02
317.17
Date Insider Type Main position Quantity % Market Cap.
06-07Sell

General Counsel

-762 0.0009%
05-10Sell

Chief Executive Officer

-5,903 0.0072%
03-25Free

Executive/Senior Manager

1,665 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
+0.73%+4.17%+3.01%+12.83% 21.74B
+1.60%+13.96%+60.65%+429.03% 37.23B
+3.63%+3.52%-21.45%-40.76% 6.77B
+1.44%+9.96%+5.33%+80.37% 4.57B
+1.76%+2.26%+23.42%+60.13% 2.94B
+3.55%+9.14%+40.04%-24.20% 1.72B
+2.86%+11.49%-26.02%+1,028.47% 1.89B
-0.96%-3.02%-15.44%-67.76% 1.63B
+1.71%+4.32%+20.11%-1.90% 1.58B
+6.78%+23.45%+91.36%-15.34% 1.68B
Average +2.32%+6.23%+18.10%+146.09% 8.18B
Weighted average by Cap. +1.66%+8.27%+29.98%+223.58%

Financials

2026 *2027 *
Net sales 14.76B 12.96B 11.94B 11.17B 20.95B 1,393B 21.33B 143B 55.51B 686B 55.42B 54.21B 2,386B 15.42B 13.54B 12.48B 11.67B 21.88B 1,455B 22.28B 150B 57.99B 717B 57.9B 56.63B 2,492B
Net income 1.18B 1.04B 957M 895M 1.68B 112B 1.71B 11.48B 4.45B 54.99B 4.44B 4.34B 191B 1.23B 1.08B 999M 934M 1.75B 116B 1.78B 11.98B 4.64B 57.4B 4.63B 4.53B 199B
Net Debt 4.63B 4.07B 3.75B 3.51B 6.58B 437B 6.7B 45B 17.43B 216B 17.4B 17.02B 749B 3.94B 3.46B 3.19B 2.98B 5.6B 372B 5.7B 38.29B 14.83B 183B 14.81B 14.48B 637B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
26-06-25 US$266.49 +0.49% 152,440
26-06-24 US$265.18 +2.55% 632,765
26-06-23 US$258.59 +1.64% 414,725
26-06-22 US$254.43 -0.54% 784,900
26-06-18 US$255.82 -1.44% 1,249,804
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
265.18USD
Average target price
310.12USD
Spread / Average Target
+16.95%

Quarterly revenue - Rate of surprise